Mark Leonard Zangardi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of CincinnatiPharmD, 2014
Publications & Presentations
PubMed
- 113 citationsCDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions.Laura Spring, Seth A. Wander, Mark L. Zangardi, Aditya Bardia
Current Oncology Reports. 2019-02-26 - 20 citationsPilot Randomized Trial of a Pharmacy Intervention for Older Adults with CancerRyan D. Nipp, Margaret Ruddy, Charn-Xin Fuh, Mark L. Zangardi, Christine Chio
The Oncologist. 2019-02-01 - 6 citationsSacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?Mark L. Zangardi, Laura Spring, Aiko Nagayama, Aditya Bardia
Expert Opinion on Investigational Drugs. 2019-02-01
Office
3595 Olentangy River Rd
Columbus, OH 43214Phone+1 614-566-5456
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
